Severity of H1N1 influenza linked to presence of Streptococcus pneumoniae – The presence of the Streptococcus pneumoniae in samples that can be easily obtained in clinics and emergency rooms may predict risk of severe disease in H1N1 pandemic influenza.
Researchers take the inside route to halt bleeding — Synthetic platelets halve clotting time – Blood loss is a major cause of death from roadside bombs to freeway crashes. Traumatic injury, the leading cause of death for people age 4 to 44, often overwhelms the body’s natural blood-clotting process.
Pennsylvania Department of health urges expanded h1n1 vaccination efforts to include all patients – Certified healthcare providers who have already immunized patients most at risk of complications from the H1N1 flu virus may now offer the vaccine to anyone who wants it, the Department of Health announced today.
State Public Health Director Announces Expansion of H1N1 Flu Vaccine Availability to all Illinoisans — High-risk individuals encouraged to be vaccinated before expansion next week. – Illinois Department of Public Health Director Dr. Damon T. Arnold announced that beginning Tuesday, December_15, 2009, all Illinoisans will be eligible to receive an H1N1 flu vaccination.
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility – Novartis inaugurated the US’s first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.
Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it — Most who tried and didn’t get it say they will try again. – In US, majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so, revealed in a poll from Harvard School of Public Health (HSPH).
Most would refuse emergency use H1N1 vaccine or additive — 70 percent said they would refuse the vaccine outright. – A new survey hinted that the majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration.
Study find that vaccination of children and 70 percent of U.S. population could control swine flu pandemic – An aggressive vaccination program that first targets children and ultimately reaches 70 percent of the U.S. population would mitigate pandemic influenza H1N1 that is expected this fall, revealed by researchers.
Retail medical clinics can provide care at lower cost, similar quality as other settings – Retail medical clinics located in pharmacies and other stores can provide care for routine illnesses at a lower cost and similar quality as offered in physician offices, urgent care centers or emergency departments, according to a new RAND Corporation study.
Shri Azad announces new decisions for tackling H1N1 – Influenza a (H1N1) in India – Indian Minister for Health and Family Welfare reviewed the situation of the Influenza A H1N1 outbreak in the country. The Cabinet Secretary also attended the review meeting.
U.S. Food and Drug Administration (FDA) Authorizes Emergency Use of Another Test for 2009 H1N1 Influenza Virus – The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza – BioCryst Pharmaceuticals (Nasdaq: BCRX) announced positive results from two Phase 3 studies of intravenous (i.v.) peramivir in patients with seasonal influenza.
